Skip to main content

Table 1 Demographic and clinical characteristics of PD patients with Stenotrophomonas maltophilia peritonitis

From: A retrospective study of patients with Stenotrophomonas maltophilia peritonitis undergoing peritoneal dialysis

No.

1

2

3

4

5

Age (years)/Sex

63/M

64/M

53/M

71/M

79/F

Dialysis duration (months)

11.8

13.3

15.0

10.2

4.7

Primary KD

DN

DN

DN

DN

Unknown

Number of previous peritonitis episodes

0

1

0

0

1

Concomitant exit site or tunnel infection

Polymicrobial infection

Enterococcus faecalis

Antibiotic therapy

CEZ + ISP → VCM + MEPM → CAZ + PZFX → MINO + LVFX + TMP–SMX

MINO + PZFX + TMP–SMX → PZFX + TMP–SMX + FLCZ

CEZ + ISP → VCM + MEPM → VCM + PZFX

CEZ + ISP → VCM + MEPM → PZFX + RFP → CAZ + RFP

CEZ + ISP → PZFX

Outcome

Continued PD

Catheter removal

Catheter removal

Catheter removal

Catheter removal

  1. M male; F female; KD kidney disease; DN diabetic nephropathy; BMI body mass index; CEZ cefazolin; ISP isepamicin; VCM vancomycin; MEPM meropenem; CAZ ceftazidime; PZFX pazufloxacin; MINO minocycline; LVFX levofloxacin; TMP–SMX trimethoprim–sulfamethoxazole; FLCZ fosfluconazole; RFP rifampicin